458 related articles for article (PubMed ID: 16238798)
1. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
Iino Y; Nagamine H; Kakizaki K; Komiya T; Katano H; Saruya S; Kodera K
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
5. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
Iino Y; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Kanazawa H; Yoshida N
Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
[TBL] [Abstract][Full Text] [Related]
6. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.
Iino Y; Kakizaki K; Saruya S; Katano H; Komiya T; Kodera K; Ohta K
Arch Otolaryngol Head Neck Surg; 2006 Oct; 132(10):1109-14. PubMed ID: 17043260
[TBL] [Abstract][Full Text] [Related]
7. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
8. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
Kanazawa H; Yoshida N; Shinnabe A; Iino Y
Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils are activated in middle ear mucosa and middle ear effusion of patients with intractable otitis media associated with bronchial asthma.
Iino Y; Nagamine H; Yabe T; Matsutani S
Clin Exp Allergy; 2001 Jul; 31(7):1135-43. PubMed ID: 11468006
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
Uchimizu H; Matsuwaki Y; Kato M; Otori N; Kojima H
Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
[TBL] [Abstract][Full Text] [Related]
11. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.
Iino Y; Usubuchi H; Kodama K; Takizawa K; Kanazawa T; Ohta Y
Otol Neurotol; 2008 Oct; 29(7):949-52. PubMed ID: 18758390
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils.
Shin SH; Park JY; Jeon CH; Choi JK; Lee SH
Laryngoscope; 2000 Aug; 110(8):1353-7. PubMed ID: 10942140
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
14. Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients.
Yao T; Kojima Y; Koyanagi A; Yokoi H; Saito T; Kawano K; Furukawa M; Kusunoki T; Ikeda K
Laryngoscope; 2009 Jun; 119(6):1053-9. PubMed ID: 19296494
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil infiltration and activation in nasal polyposis.
Fan GK; Wang H; Takenaka H
Acta Otolaryngol; 2007 May; 127(5):521-6. PubMed ID: 17453479
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.
Jahnsen FL; Haye R; Gran E; Brandtzaeg P; Johansen FE
J Immunol; 1999 Aug; 163(3):1545-51. PubMed ID: 10415058
[TBL] [Abstract][Full Text] [Related]
17. Expression of ecalectin, a novel eosinophil chemoattractant, in nasal polyps.
Iino Y; Miyazawa T; Kakizaki K; Saigusa H; Katano H; Shiga J; Kanegasaki S
Acta Otolaryngol; 2006 Jan; 126(1):43-50. PubMed ID: 16308254
[TBL] [Abstract][Full Text] [Related]
18. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
[TBL] [Abstract][Full Text] [Related]
19. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion.
Nonaka M; Fukumoto A; Ozu C; Mokuno E; Baba S; Pawankar R; Yagi T
Acta Otolaryngol; 2003 Apr; 123(3):383-7. PubMed ID: 12737295
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with severity of eosinophilic otitis media.
Kanazawa H; Yoshida N; Yamamoto H; Hara M; Hasegawa M; Matsuzawa S; Shinnabe A; Iino Y
Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
